Related references
Note: Only part of the references are listed.The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus
Laura K. McMullan et al.
ANTIVIRAL RESEARCH (2016)
The efficacy and pharmacokinetics of brincidofovir for the treatment of lethal rabbitpox virus infection: A model of smallpox disease
Lawrence C. Trost et al.
ANTIVIRAL RESEARCH (2015)
Clinical Predictors of Mortality in Patients With Ebola Virus Disease
Moumie Barry et al.
CLINICAL INFECTIOUS DISEASES (2015)
Clinical Presentation of Patients with Ebola Virus Disease in Conakry, Guinea
Elhadj Ibrahima Bah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Evaluating Clinical Trial Designs for Investigational Treatments of Ebola Virus Disease
Ben S. Cooper et al.
PLOS MEDICINE (2015)
Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses
Diana F. Florescu et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2014)
Clinical Care of Two Patients with Ebola Virus Disease in the United States
G. Marshall Lyon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone
J. S. Schieffelin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ebola Virus Disease in West Africa - Clinical Manifestations and Management
Daniel S. Chertow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation
Francisco M. Marty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
First Pharmacokinetic and Safety Study in Humans of the Novel Lipid Antiviral Conjugate CMX001, a Broad-Spectrum Oral Drug Active against Double-Stranded DNA Viruses
Wendy Painter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised Patients
Diana F. Florescu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Development of CMX001 for the Treatment of Poxvirus Infections
Randall Lanier et al.
VIRUSES-BASEL (2010)
Mechanism of inhibition of vaccinia virus DNA polymerase by cidofovir diphosphate
WC Magee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)